Syntara Limited Stock: price and insider trades · Australia
Syntara Limited: what insiders have been doing
Syntara Limited is a Health Care company. Its directors and officers file their transactions with ASX. From 1 November 2025 to 1 November 2026, the disclosure feed for Syntara Limited logged 3 filings by 2 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
There has been no open-market purchase by an insider of Syntara Limited for at least a year.
Across the 1,612 companies tracked on its exchange, the median is 5 filings; at 3 filings, this issuer sits below that mark.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ●Executives0ASX
- ●Executives0ASX
- ●Executives0ASX
3 of 3 declarations
About Syntara Limited
Syntara Limited is a company focused on the health and pharmaceutical sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
